KBR (NYSE:KBR) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below provides a snapshot of their recent ...

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better. KBR, Inc. is a global engineering, construction and services firm supporting the market segments of global ...

Researchers at the University of Gothenburg have identified a molecule that helps more mitochondria function properly. Mitochondrial diseases caused by POLG mutations vary in severity. In young ...

Numerous articles and posts that deal with the issue of love intoxication mention phenylethylamine (or PEA), describing it as a specific “love molecule” that is released in the brain and acts ...

In addition, we determine the structures of C3aR in complex with the synthetic small-molecule agonist JR14a in two distinct conformational states: a G protein-free intermediate, and a fully active G i ...

SAN DIEGO--(BUSINESS WIRE)--RayThera, Inc., a recently founded biotechnology company currently focused on discovering and developing small molecule therapies in immunology, announced today that it ...

Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, College of Pharmaceutical Sciences, Zhejiang University of Technology, China; Department of Molecular, Cellular, ...

In this article, we are going to take a look at where KBR Inc. (NYSE:KBR) stands against other best engineering stocks to invest in now. The global engineering services market was valued at $3.26 ...

The new molecule, called lariocidin, works by targeting a part of a bacteria’s cell called the ribosome and can disrupt the cell’s functions. "This is a new molecule with a new mode of action.